sepsis and the kidney.pdf - SASSiT

222
klenzak & himmelfarb
[31] Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous
hemofiltration in sepsis. Crit Care Med 2002;30:100– 6.
[32] Klouche K, Cavadore P, Portales P, et al. Continuous veno-venous hemofiltration improves
hemodynamics in septic shock with acute renal failure without modifying TNF-alpha and IL-6
plasma concentrations. J Nephrol 2002;15:150–7.
[33] Morgera S, Haase M, Rocktaschel J, et al. High permeability haemofiltration improves peripheral
blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial
Transplant 2003;18:2570–6.
[34] Lonnemann G, Bechstein M, Linnenweber S, et al. Tumor necrosis factor-alpha during
continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 1999;
72:S84–7.
[35] Stegmayr BG. Plasma exchange in patients with septic shock including acute renal failure.
Blood Purif 1996;14:102–8.
[36] Busund R, Koukline V, Utrobin U, et al. Plasmapheresis in severe sepsis and septic shock:
a prospective, randomised, controlled trial. Intensive Care Med 2002;28:1434–9.
[37] Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with
adsorption in septic shock. Crit Care Med 2002;30:1250–5.
[38] Fissell WH, Lou L, Abrishami S, et al. Bioartificial kidney ameliorates gram-negative bacteriainduced
septic shock in uremic animals. J Am Soc Nephrol 2003;14:454–61.
[39] Fissell WH, Dyke DB, Weitzel WF, et al. Bioartificial kidney alters cytokine response and
hemodynamics in endotoxin-challenged uremic animals. Blood Purif 2002;20:55– 60.
[40] Humes HD, Buffington DA, Lou L, et al. Cell therapy with a tissue-engineered kidney reduces
the multiple-organ consequences of septic shock. Crit Care Med 2003;31:2421– 8.